Mohammad Abdollahi Selected Research

Tumor Necrosis Factors

7/2007	Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.
1/2007	Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Abdollahi Research Topics

Disease

40	Poisoning 05/2022 - 08/2003
38	Inflammation (Inflammations) 04/2022 - 02/2005
28	Neoplasms (Cancer) 01/2022 - 10/2012
25	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 11/2004
16	Obesity 01/2021 - 07/2009
15	Wounds and Injuries (Trauma) 01/2022 - 08/2009
15	Body Weight (Weight, Body) 01/2022 - 09/2007
14	Colitis 07/2018 - 01/2006
13	Hyperglycemia 01/2021 - 04/2004
13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2010
13	Diabetes Mellitus 09/2020 - 01/2013
13	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 05/2008
11	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2013
11	Pain (Aches) 07/2020 - 02/2004
10	Sepsis (Septicemia) 05/2021 - 12/2011
10	Insulin Resistance 01/2021 - 07/2008
10	Ulcerative Colitis 01/2019 - 01/2007
9	Cardiotoxicity 01/2022 - 01/2015
9	Crohn Disease (Crohn's Disease) 01/2020 - 12/2006
9	Necrosis 05/2017 - 07/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2015
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2020 - 01/2018
8	Critical Illness (Critically Ill) 05/2017 - 07/2004
7	Constipation 06/2020 - 05/2008
7	Abdominal Pain (Pain, Abdominal) 01/2019 - 05/2008
7	Osteoporosis 06/2018 - 12/2006
7	Hyperlipidemias (Hyperlipidemia) 06/2018 - 09/2003
7	Multiple Sclerosis 01/2018 - 04/2010
7	Mitochondrial Diseases (Mitochondrial Disease) 05/2017 - 01/2012
6	COVID-19 01/2022 - 01/2020
6	Diarrhea 01/2020 - 04/2011
5	Burns 01/2022 - 09/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2008
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2018 - 03/2009
5	Melanoma (Melanoma, Malignant) 03/2018 - 10/2013
5	Chronic Disease (Chronic Diseases) 01/2015 - 08/2005
4	Infections 01/2022 - 02/2003
4	Congenital Abnormalities (Deformity) 01/2022 - 01/2017
4	Ulcer 01/2022 - 03/2015
4	Neuroinflammatory Diseases 01/2022 - 01/2017
4	Leukemia 12/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

44	AntioxidantsIBA 05/2021 - 11/2004
35	Pharmaceutical PreparationsIBA 01/2022 - 02/2003
17	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2006
16	Biomarkers (Surrogate Marker)IBA 06/2020 - 03/2011
16	Plant ExtractsIBA 03/2020 - 03/2009
15	aluminum phosphideIBA 05/2022 - 03/2011
13	Free RadicalsIBA 01/2020 - 07/2005
12	LipidsIBA 01/2020 - 09/2003
12	MelatoninIBA 03/2018 - 01/2010
11	EnzymesIBA 01/2021 - 05/2005
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2020 - 11/2004
10	PhytochemicalsIBA 01/2022 - 01/2014
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
10	Blood Glucose (Blood Sugar)IBA 01/2021 - 09/2007
10	CytokinesIBA 05/2020 - 03/2011
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2007
9	Adenosine Triphosphate (ATP)IBA 11/2021 - 08/2010
9	Therapeutic UsesIBA 01/2021 - 01/2013
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2005
9	Insulin (Novolin)FDA Link 01/2020 - 09/2007
8	Biological ProductsIBA 11/2020 - 01/2010
8	PesticidesIBA 01/2018 - 03/2011
7	Opioid Analgesics (Opioids)IBA 06/2020 - 09/2007
7	OrganophosphatesIBA 07/2017 - 03/2006
6	Metformin (Glucophage)FDA LinkGeneric 04/2022 - 07/2008
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2006
6	CurcuminIBA 01/2022 - 01/2015
6	phosphine (phosphane)IBA 12/2021 - 03/2011
6	AcidsIBA 07/2018 - 11/2007
6	OpiumIBA 01/2018 - 01/2007
6	Thiobarbituric Acid Reactive SubstancesIBA 08/2014 - 11/2005
5	Streptozocin (Streptozotocin)FDA Link 09/2022 - 09/2003
5	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2018
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 07/2008
5	Superoxide DismutaseIBA 01/2019 - 09/2007
5	Cholinergic Agents (Cholinergics)IBA 11/2018 - 03/2006
5	PolyphenolsIBA 07/2017 - 01/2015
5	Sulfhydryl Compounds (Thiols)IBA 07/2017 - 07/2005
5	Volatile Oils (Essential Oils)IBA 01/2017 - 04/2004
5	Monoclonal AntibodiesIBA 01/2017 - 04/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 05/2013
5	Peroxidase (Myeloperoxidase)IBA 12/2014 - 04/2010
5	Sulfonic AcidsIBA 12/2014 - 08/2010
5	Infliximab (Remicade)FDA Link 03/2013 - 07/2007
5	Malathion (Karbofos)FDA LinkGeneric 01/2012 - 04/2004
4	Neuroprotective AgentsIBA 09/2022 - 01/2017
4	Synthetic DrugsIBA 01/2022 - 11/2013
4	Adenosine Diphosphate (ADP)IBA 11/2021 - 11/2010
4	ArsenicIBA 10/2021 - 01/2017
4	Serotonin (5 Hydroxytryptamine)IBA 07/2021 - 05/2008
4	FlavonoidsIBA 04/2021 - 12/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019 - 01/2007

Therapy/Procedure

60	Therapeutics 01/2022 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2022 - 02/2012
5	Persian Medicine 01/2021 - 03/2015
5	Traditional Medicine (Folk Remedies) 01/2017 - 07/2009
5	Phytotherapy (Herbal Therapy) 01/2016 - 11/2011
5	Oral Administration 04/2015 - 04/2004
4	Intravenous Administration 01/2021 - 04/2004